Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
donanemab
donanemab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
kisunla
SPC - EMA
donanemab
Eli Lilly Nederland B.V.
Kisunla 350 mg concentrate for solution for infusion
New
SPC
PIL
No
A
donanemab
Eli Lilly and Company (Ireland) Limited
Cookies
Direct Healthcare Professional Communications
This medicine was published on medicines.ie in the last 30 days.
Product subject to medical prescription which may not be renewed (A)
